Yan Wang1, Gladys E Ibañez2, Krishna Vaddiparti3, Nichole E Stetten4, Ruba Sajdeya3, Eric C Porges5, Ronald A Cohen5, Robert L Cook3. 1. Department of Epidemiology, The University of Florida, United States. Electronic address: ywang48@ufl.edu. 2. Department of Epidemiology, Florida International University, United States. 3. Department of Epidemiology, The University of Florida, United States. 4. Department of Occupational Therapy, The University of Florida, United States. 5. Center for Cognitive Aging and Memory, Department of Clinical and Health Psychology, The University of Florida, United States.
Abstract
BACKGROUND: Emerging literature shows increased drug use during the COVID-19 pandemic. However, limited research has examined the change in marijuana use among persons living with HIV (PLWH). This study aimed to investigate how marijuana use changed in a cohort of PLWH during the first year of the pandemic and identify factors associated with the change. METHOD: 222 PLWH (mean age = 50.2 ± 11.2, 50.9 % female, 14.5 % Hispanic, 64.7 % Black, 15.8 % White, 5 % other, 80.2 % persons using marijuana [at least weekly use], 19.8 % persons not using marijuana) completed a baseline survey on demographics and behavioral/health characteristics between 2018 and 2020 and a brief phone survey between May and October 2020 that assessed changes in marijuana use and overall/mental health, and perceived risks/benefits of marijuana use during the COVID-19 pandemic. RESULTS: During the pandemic, 64/222(28.8 %) of the whole sample reported increased marijuana use, 36(16.2 %) reported decreased use, and 122(55 %) reported no change. Multinomial logistic regression results indicated that: Compared to those reporting no change, increased marijuana use during the pandemic was associated with more frequent marijuana use and PTSD symptoms at baseline, worsened mental health during the pandemic, and not perceiving marijuana use as a risk factor for COVID-19 infection. More frequent marijuana use at baseline was the only factor significantly associated with decreased marijuana use during the pandemic. CONCLUSION: The COVID-19 pandemic has resulted in changes in marijuana use among a considerable proportion (45 %) of PLWH. Future research is needed to understand the temporality of the increases in marijuana use with worsening mental health.
BACKGROUND: Emerging literature shows increased drug use during the COVID-19 pandemic. However, limited research has examined the change in marijuana use among persons living with HIV (PLWH). This study aimed to investigate how marijuana use changed in a cohort of PLWH during the first year of the pandemic and identify factors associated with the change. METHOD: 222 PLWH (mean age = 50.2 ± 11.2, 50.9 % female, 14.5 % Hispanic, 64.7 % Black, 15.8 % White, 5 % other, 80.2 % persons using marijuana [at least weekly use], 19.8 % persons not using marijuana) completed a baseline survey on demographics and behavioral/health characteristics between 2018 and 2020 and a brief phone survey between May and October 2020 that assessed changes in marijuana use and overall/mental health, and perceived risks/benefits of marijuana use during the COVID-19 pandemic. RESULTS: During the pandemic, 64/222(28.8 %) of the whole sample reported increased marijuana use, 36(16.2 %) reported decreased use, and 122(55 %) reported no change. Multinomial logistic regression results indicated that: Compared to those reporting no change, increased marijuana use during the pandemic was associated with more frequent marijuana use and PTSD symptoms at baseline, worsened mental health during the pandemic, and not perceiving marijuana use as a risk factor for COVID-19 infection. More frequent marijuana use at baseline was the only factor significantly associated with decreased marijuana use during the pandemic. CONCLUSION: The COVID-19 pandemic has resulted in changes in marijuana use among a considerable proportion (45 %) of PLWH. Future research is needed to understand the temporality of the increases in marijuana use with worsening mental health.
Authors: Chukwuemeka N Okafor; Zhi Zhou; Larry E Burrell; Natalie E Kelso; Nicole E Whitehead; Jeffery S Harman; Christa L Cook; Robert L Cook Journal: Am J Drug Alcohol Abuse Date: 2016-07-11 Impact factor: 3.829
Authors: Benedikt Fischer; Cayley Russell; Pamela Sabioni; Wim van den Brink; Bernard Le Foll; Wayne Hall; Jürgen Rehm; Robin Room Journal: Am J Public Health Date: 2017-06-23 Impact factor: 9.308
Authors: Bryan Hartzler; Beatriz H Carlini; Howard Newville; Heidi M Crane; Joseph J Eron; Elvin H Geng; W Christopher Mathews; Kenneth H Mayer; Richard D Moore; Michael J Mugavero; Sonia Napravnik; Benigno Rodriguez; Dennis M Donovan Journal: AIDS Care Date: 2016-12-23
Authors: Ronald J Ellis; Will Toperoff; Florin Vaida; Geoffrey van den Brande; James Gonzales; Ben Gouaux; Heather Bentley; J Hampton Atkinson Journal: Neuropsychopharmacology Date: 2008-08-06 Impact factor: 7.853
Authors: Zachary L Mannes; Larry E Burrell; Erin G Ferguson; Zhi Zhou; Huiyin Lu; Charurut Somboonwit; Robert L Cook; Nicole Ennis Journal: Patient Prefer Adherence Date: 2018-07-27 Impact factor: 2.711
Authors: Steven Meanley; Seul Ki Choi; Azure B Thompson; Jacquelyn L Meyers; Gypsyamber D'Souza; Adaora A Adimora; Matthew J Mimiaga; Mirjam-Colette Kempf; Deborah Konkle-Parker; Mardge H Cohen; Linda A Teplin; Lynn Murchison; Leah H Rubin; Anna A Rubtsova; Deborah Jones Weiss; Brad Aouizerat; Mackey R Friedman; Michael W Plankey; Tracey E Wilson Journal: Drug Alcohol Depend Date: 2021-12-25 Impact factor: 4.492
Authors: Christina E Parisi; Deepthi S Varma; Yan Wang; Krishna Vaddiparti; Gladys E Ibañez; Liset Cruz; Robert L Cook Journal: AIDS Behav Date: 2022-01-07
Authors: Angel B Algarin; Gabriela N Plazarte; Kaitlin R Sovich; Stella D Seeger; Yancheng Li; Ronald A Cohen; Catherine W Striley; Bruce A Goldberger; Yan Wang; Charurut Somboonwit; Gladys E Ibañez; Emma C Spencer; Robert L Cook Journal: JMIR Res Protoc Date: 2022-08-30